1. In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitor. Issue 12 (18th October 2020) Authors: Ariey‐Bonnet, Jeremy; Carrasco, Kendall; Le Grand, Marion; Hoffer, Laurent; Betzi, Stéphane; Feracci, Mikael; Tsvetkov, Philipp; Devred, Francois; Collette, Yves; Morelli, Xavier; Ballester, Pedro; Pasquier, Eddy Journal: Molecular oncology Issue: Volume 14:Issue 12(2020) Page Start: 3083 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗